Vice President
AstraZeneca
Cambridge, England, United Kingdom
Dr. Maria M. Flocco
VP, Mechanistic and Structural Biology, Biopharmaceuticals R&D, AstraZeneca
Dr. Flocco is Vice President, Global Head of Mechanistic and Structural Biology at AstraZeneca.
Maria has 25 years of pharmaceutical industry and drug discovery experience. Previous to joining AstraZeneca, she held various positions of increasing responsibility in Pfizer. She was Senior Director and Head of External R&D Innovation Europe, Sr Dir and Head of Internal Medicine Chemistry, Sr Dir and Head of Lead Discovery, and Director and Head of Structural Biology and Biophysics. Before joining Pfizer, Maria was Head of Structural Chemistry at Pharmacia.
Prior to her career in the pharmaceutical industry, Maria was a lecturer at the Karolinska Institute, Stockholm, and a researcher at the Uppsala Biomedical Centre, Sweden. Maria received a PhD in Physical Chemistry from the City University of New York, and postdoctoral training in X-ray crystallography at the Fox Chase Cancer Centre, Philadelphia, and the
Uppsala Biomedical Centre.
Maria is a member of the Structural Biology Advisory Panel of the Rosalind Franklin Institute, Oxford. During her career, she has been a member of the MRC Molecular and Cellular Medicine Board, the SAB of the Chemical Biology Institute of Imperial College London, the SAB of INSTRUCT EU, and the SAB of INSERM Transfert Initiative, a seed funding body from INSERM in France. She is a co-founder and co-organiser of the Next Generation Biophysics Symposium, Cambridge UK.
Maria has a track record of successfully embracing innovative approaches and expanding capabilities that make an impact on drug discovery.
Disclosure information not submitted.
Opportunities and Challenges in the Evolving Landscape of Early Drug Discovery
Wednesday, May 29, 2024
16:30 – 17:30 CEST